Filings
Finds words inside filing documents. Searching SAB Biotherapeutics, Inc.'s filings · 32 documents indexed.
4 documents · 13 matches
-
SABS SAB Biotherapeutics, Inc. 10-Q 2026-11-05
Item 1. Condensed Consolidated Financial Statements (Unaudited).
going concern rather than face dissolution before 2028. The probability of survival was 70.0% and 40.0% as of September 30, 2026 and December1 match in this document -
SABS SAB Biotherapeutics, Inc. 10-Q 2026-08-06
Item 1. Condensed Consolidated Financial Statements (Unaudited).
going concern rather than face dissolution before 2028. The probability of survival was 57.5% and 40.0% as of June 30, 2026 and December1 match in this document -
SABS SAB Biotherapeutics, Inc. 10-K 2026-03-09
Item 16.
our ability to continue as a going concern.2 matches in this document -
SABS SAB Biotherapeutics, Inc. 10-Q 2025-05-09
Item 1. Condensed Consolidated Financial Statements (Unaudited).
Liquidity and Going Concern9 matches in this document
Page 1 of 1 · 4 documents